FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

32449011000001107: Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1864961000001111 Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1864971000001118 Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) Is a Product containing precisely ursodeoxycholic acid 250 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) Has active ingredient Ursodeoxycholic acid false Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) Has specific active ingredient Ursodeoxycholic acid true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) 60 capsule Has AMP True Ursodeoxycholic acid 250mg capsules (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start